Clinical Trial Update: Arestin - Use in Subjects With Peri-Implantitis [Phase 3]

View source ↗

Summary

Phase 3 trial of Arestin for peri-implantitis completed; study evaluated use of minocycline microspheres in subjects with peri-implantitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peri-implantitis

Drugs mentioned

• ARESTIN (MINOCYCLINE HYDROCHLORIDE)

Snippet

Sponsor: OraPharma | Conditions: Peri-Implantitis | Phase 3 | Status: COMPLETED